Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
neostigmine (bloxiverz) (1 trial)
sugammadex (bridion) (1 trial)
Trials (1 total)
Trial APIs (2 total)